HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Adoptive transfer of an anti-MART-1(27-35)-specific CD8+ T cell clone leads to immunoselection of human melanoma antigen-loss variants in SCID mice.

Abstract
The identification of appropriate mouse models could be useful in carefully evaluating the actual role of the in vivo development of antigen-loss variants during antigen-specific vaccine therapy of human tumors. In this study we investigated the level of efficacy of a MART-1/Melan-A-specific CD8+ T cell clone against its autologous melanoma in a severe combined immunodeficiency (SCID) mouse model, in which the tumor cells expressed in vivo heterogeneous and suboptimal levels of MART-1. The subcutaneous co-injection of the MART-1/Melan-A-reactive T cell clone A42 with MART-1/Melan-A+ autologous human melanoma cells into SCID mice caused a total inhibition of tumor growth. However, the systemic treatment with A42 clone lymphocytes resulted in only 50-60% inhibition of tumor growth, although the T cell clone targeted the tumors and the MART-1+ cells virtually disappeared from the tumors. This study suggests that an immunotherapy based on the expansion of an antigen-specific T cell clone generated in vitro is highly efficient in abolishing tumor growth when the target antigen is fully expressed, but leads to in vivo immunoselection of antigen-loss variants in the presence of suboptimal levels of antigen expression. Furthermore, this work shows that human tumors/SCID mouse models may be useful in evaluating the in vivo efficacy of adoptive immunotherapies.
AuthorsFrancesco Lozupone, Licia Rivoltini, Francesca Luciani, Massimo Venditti, Luana Lugini, Agata Cova, Paolo Squarcina, Giorgio Parmiani, Filippo Belardelli, Stefano Fais
JournalEuropean journal of immunology (Eur J Immunol) Vol. 33 Issue 2 Pg. 556-66 (Feb 2003) ISSN: 0014-2980 [Print] Germany
PMID12645955 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, Neoplasm
  • Epitopes
  • MART-1-Melan-A(27-35) epitope
  • Neoplasm Proteins
Topics
  • Animals
  • Antigens, Neoplasm (analysis, genetics, immunology)
  • CD8-Positive T-Lymphocytes (immunology, transplantation)
  • Clone Cells (immunology, transplantation)
  • Epitopes (analysis, immunology)
  • Female
  • Humans
  • Immunotherapy, Adoptive
  • Injections, Intravenous
  • Lymphocyte Activation
  • Melanoma (immunology, therapy)
  • Mice
  • Mice, SCID
  • Neoplasm Proteins (analysis, immunology)
  • Selection, Genetic
  • T-Lymphocytes, Cytotoxic (immunology, transplantation)
  • Tumor Escape
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: